Please use this identifier to cite or link to this item:
Title: Marker Methodology With Focus On Hierarchical Outcomes
Authors: TILAHUN ESHETE, Abel 
Advisors: MOLENBERGHS, Geert
Issue Date: 2009
Abstract: Statistical methods that can be used for the selection and evaluation of biomarkers which later will be validated to graduate into potent surrogate markers are in dire demand. The selected biomarkers need to go through rigorous testing procedures both statistically as well as biologically to finally end up being reliable replacements for the clinically relevant endpoint. The competitive nature of the pharmaceutical industry and the impending societal demand for urgent drugs for some of the chronic diseases threatening human life add to the need for these methods. In this thesis we have revised some existing methods, introduced some new once and assessed their merit through simulation studies. The thesis is organized in to two parts. The first part dealt with surrogate marker validation and the second one is devoted to the selection and evaluation of biomarkers mainly genomic biomarkers from microarray experiments. This however is not the natural ordering of the events. In practice, we first identify a biomarker which later will be promoted to a surrogate endpoint. However, the aim here is to introduce a set of methods that have been designed to validate a surrogate endpoint for the selection and evaluation of biomarkers.
Document URI:
Category: T1
Type: Theses and Dissertations
Appears in Collections:PhD theses
Research publications

Files in This Item:
File Description SizeFormat 
Abel Tilahun.pdf1.05 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 24, 2022


checked on May 24, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.